Total Payments
$3,054
2024 Payments
$90.69
Companies
13
Transactions
49
Medicare Patients
13,690
Medicare Billing
$4.1M
Payment Breakdown by Category
Food & Beverage$1,664 (54.5%)
Travel$1,143 (37.4%)
Other$246.87 (8.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,664 | 41 | 54.5% |
| Travel and Lodging | $1,143 | 7 | 37.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $246.87 | 1 | 8.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $1,754 | 21 | $0 (2021) |
| Alcon Research Ltd | $301.64 | 1 | $0 (2018) |
| Notal Vision, Inc. | $246.87 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $157.55 | 4 | $0 (2021) |
| Abbott Laboratories | $118.33 | 1 | $0 (2023) |
| Alcon Laboratories Inc | $99.20 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $97.56 | 4 | $0 (2024) |
| ABBVIE INC. | $77.23 | 4 | $0 (2024) |
| Allergan, Inc. | $68.76 | 4 | $0 (2021) |
| Genentech USA, Inc. | $67.98 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $90.69 | 4 | Dutch Ophthalmic, USA ($24.19) |
| 2023 | $230.69 | 6 | Abbott Laboratories ($118.33) |
| 2022 | $328.70 | 6 | Notal Vision, Inc. ($246.87) |
| 2021 | $89.80 | 6 | Allergan, Inc. ($34.57) |
| 2020 | $91.15 | 5 | Bausch & Lomb, a division of Bausch Health US, LLC ($56.96) |
| 2019 | $1,584 | 16 | Bausch & Lomb, a division of Bausch Health US, LLC ($1,584) |
| 2018 | $600.05 | 4 | Alcon Research Ltd ($301.64) |
| 2017 | $39.81 | 2 | Novartis Pharmaceuticals Corporation ($39.81) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/13/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: EYE CARE | ||||||
| 02/21/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/01/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/30/2024 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Ophthalmology | ||||||
| 12/06/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/23/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: EYE CARE | ||||||
| 11/21/2023 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Ophthalmology | ||||||
| 11/14/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $118.33 | General |
| Category: Neuromodulation | ||||||
| 09/12/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $31.04 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/14/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/29/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/21/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: RETINA | ||||||
| 08/30/2022 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: RETINA | ||||||
| 05/19/2022 | Notal Vision, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $246.87 | General |
| 04/18/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/24/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/27/2021 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $10.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/06/2021 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/16/2021 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $12.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/04/2021 | Allergan, Inc. | RESTASIS MULTIDOSE (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: DRY EYE | ||||||
| 02/17/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Ophthalmology | ||||||
| 01/07/2021 | Allergan, Inc. | RESTASIS MULTIDOSE (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: DRY EYE | ||||||
| 12/21/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/10/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/05/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 5,672 | 20,655 | $4.0M | $2.0M |
| 2022 | 18 | 5,053 | 11,127 | $3.0M | $1.5M |
| 2021 | 14 | 2,664 | 3,754 | $1.0M | $539,954 |
| 2020 | 8 | 301 | 403 | $57,569 | $25,331 |
Total Patients
13,690
Total Services
35,939
Medicare Billing
$4.1M
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 323 | 1,516 | $1.9M | $1.0M | 53.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 79 | 9,720 | $480,001 | $279,960 | 58.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,530 | 2,680 | $442,200 | $247,471 | 56.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 952 | 1,863 | $504,210 | $184,296 | 36.6% |
| 92134 | Imaging of retina | Office | 2023 | 1,651 | 2,919 | $233,520 | $91,900 | 39.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 631 | 1,374 | $179,510 | $77,832 | 43.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 250 | 250 | $50,000 | $25,676 | 51.4% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2023 | 12 | 78 | $33,540 | $19,383 | 57.8% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 17 | 19 | $63,327 | $16,124 | 25.5% |
| 67121 | Removal of implant material from inside of eye | Facility | 2023 | 17 | 19 | $30,400 | $13,187 | 43.4% |
| 66985 | Insertion of prosthetic lens | Facility | 2023 | 15 | 16 | $25,200 | $4,864 | 19.3% |
| 66682 | Suture of iris and lens | Facility | 2023 | 14 | 14 | $16,800 | $3,985 | 23.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 49 | 51 | $6,120 | $3,399 | 55.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 29 | 29 | $5,655 | $2,941 | 52.0% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 12 | 12 | $13,260 | $1,994 | 15.0% |
| 65800 | Removal of eye fluid | Office | 2023 | 15 | 16 | $4,680 | $1,332 | 28.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 22 | 22 | $2,200 | $1,103 | 50.1% |
| 92250 | Photography of the retina | Office | 2023 | 37 | 38 | $3,800 | $1,076 | 28.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 17 | 19 | $2,945 | $732.45 | 24.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 276 | 1,186 | $1.5M | $851,859 | 56.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 1,361 | 2,302 | $379,830 | $215,227 | 56.7% |
| 67028 | Injection of drug into eye | Office | 2022 | 838 | 1,568 | $425,040 | $154,686 | 36.4% |
| 92134 | Imaging of retina | Office | 2022 | 1,471 | 2,494 | $199,520 | $79,520 | 39.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 569 | 1,207 | $156,910 | $65,607 | 41.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 24 | 1,560 | $78,000 | $46,552 | 59.7% |
About Evan Berger
Evan Berger is a Retina Specialist healthcare provider based in Norfolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1356769731.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Evan Berger has received a total of $3,054 in payments from pharmaceutical and medical device companies, with $90.69 received in 2024. These payments were reported across 49 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,664).
As a Medicare-enrolled provider, Berger has provided services to 13,690 Medicare beneficiaries, totaling 35,939 services with total Medicare billing of $4.1M. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Location Norfolk, VA
- Active Since 04/02/2014
- Last Updated 06/20/2025
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1356769731
Products in Payments
- STELLARIS PC (Device) $1,584
- VYZULTA (Drug) $136.39
- PROCLAIM (Device) $118.33
- AcrySof (Device) $99.20
- OZURDEX (Drug) $92.23
- EYLEA HD (Biological) $59.95
- Vabysmo (Drug) $39.87
- EYLEA (Biological) $37.61
- RESTASIS MULTIDOSE (Drug) $34.57
- LOTEMAX SM (Drug) $33.94
- VABYSMO (Drug) $28.11
- EVA, combined machine (Device) $24.19
- ILUVIEN (Drug) $23.33
- DUREZOL (Drug) $21.23
- LUMIGAN (Drug) $19.19
- PAZEO (Drug) $18.58
- XIPERE (Drug) $17.92
- BEOVU (Drug) $17.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.